In mid-May the BonePainII Consortium convened in Cambridge for its final meeting, this time at the brand new AstraZeneca Discovery Centre in Cambridge, UK.

It has been a pleasure to follow the journey of our 15 Early Stage Researchers in the BonePainII network, a European Innovative Training Network committed to promote training within bone pain. 

In 2019, the Consortium kicked-off in London. Now, three years later the 15 PhD students presented the results of their research with exiting findings from their studies on bone pain in osteoarthritis, rheumatoid arthritis, osteoporosis, cancer, fracture, and fibrous dysplasia.

We wish them the very best for their future careers.